세계의 분자 육종 시장 : 공정별, 마커별, 용도별, 지역별 예측(-2030년)

Global Molecular Breeding Market Research Report Information by Process (Marker-assisted selection, Marker-assisted backcrossing, QTL mapping), By Maker (SNP, SSR), By Application (Plant, Livestock), and Region (North America, Europe, Asia-Pacific, and South America, Middle East and Africa)-Forecast till 2030

Market Overview

Molecular Breeding Market is expected to develop at a CAGR of 16.24% during the forecast period. The market is being driven by the increasing development of high-yielding and stress-resistant molecular breeding varieties, expanding knowledge of molecular breeding, and growing consumer demand for foods with improved nutritional profiles.

The rising creation of high-yielding and stress-resistant cultivars contributes significantly to the growth of the Molecular Breeding Market. As the world population grows and environmental concerns such as climate change become more severe, there is an urgent need to develop crops and livestock varieties that can flourish in harsh conditions while remaining productive. Researchers are using molecular breeding to generate crops that can grow in dry locations in response to demand from people. Pusa 10216 demonstrated increased yields during testing in Indian drought circumstances, and the chickpea project is the first AICRP among pulse crops to select molecular breeding products for commercial release in India. As a result, research and development of high-yielding crops is driving the growth of the Molecular Breeding Market.

Market Segment insights

The process-based segmentation of the Molecular Breeding Market covers segmental marker-assisted selection, marker-assisted backcrossing, and QTL mapping.

The Molecular Breeding Market is segmented by Maker, which comprises SNPs and SSRs.

Regional insights

The market is divided into four regions: North America, Europe, Asia-Pacific, and South America, as well as the Middle East and Africa. The North American Molecular Breeding Market held the biggest market share in 2023. Genomic advances, like as next-generation sequencing and CRISPR-Cas9, have improved molecular breeding's precision and efficiency. This region benefits from significant investment in agricultural research and development from both the governmental and private sectors. Government measures that promote agricultural innovation and food security bolster the market.

The Europe Molecular Breeding Market is predicted to account for the second-largest market share due to Europe's strong research infrastructure and collaboration among research institutes and biotech businesses, establishing it as a major player in the molecular breeding industry. Furthermore, the German Molecular Breeding Market was found to have the greatest market share, while the Spanish Molecular Breeding Market is predicted to be the fastest-growing market in the European region.

The Asia-Pacific Molecular Breeding market is predicted to develop at the quickest rate between 2024 and 2032. This is owing to increased customer demand for high-quality, nutritious, and sustainable food, which is driving the use of molecular breeding. The demand for climate-resistant crops in the face of changing climatic circumstances drives market growth.

South America, the Middle East, and Africa have abundant biodiversity and agricultural potential, making them more appealing for agricultural research and investment. Growing research capacity and knowledge exchange activities boost their competitiveness in the Molecular Breeding industry, propelling industry growth.

Major Players

Key companies in the Molecular Breeding Market include Charles River Laboratories (US), Eurofins Scientific (Europe), DanBred P/S (Denmark), Intertek Group Plc (UK), Slipstream Automation (New Zealand), Illumina Inc (US), Thermo Fisher Scientific Inc (US), LGC Limited (England), SGS Societe Generale de Surveillance SA (Switzerland), and LemnaTec GmbH (Germany).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING DEVELOPMENT OF HIGH-YIELDING AND STRESS-RESISTANT VARIETIES OF MOLECULAR BREEDING
  • 4.2.2 RISING AWARENESS OF MOLECULAR BREEDING
• 4.3 RESTRAINTS
  • 4.3.1 HIGH COSTS ASSOCIATED WITH IMPLEMENTING MOLECULAR BREEDING TECHNOLOGIES
• 4.4 OPPORTUNITIES
  • 4.4.1 GROWING INVESTMENTS IN RESEARCH AND DEVELOPMENT

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 THREAT OF SUBSTITUTES
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF RIVALRY
• 5.2 IMPACT OF COVID-19 ON THE GLOBAL MOLECULAR BREEDING MARKET

6 GLOBAL MOLECULAR BREEDING MARKET, BY PROCESS

• 6.1 OVERVIEW
• 6.2 MARKER-ASSISTED SELECTION
• 6.3 MARKER-ASSISTED BACKCROSSING
• 6.4 QTL MAPPING

7 GLOBAL MOLECULAR BREEDING MARKET, BY MAKER

• 7.1 OVERVIEW
• 7.2 SNP
• 7.3 SSR

8 GLOBAL MOLECULAR BREEDING MARKET, BY APPLICATION

• 8.1 OVERVIEW
• 8.2 PLANT
• 8.3 LIVESTOCK

9 GLOBAL MOLECULAR BREEDING MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
  • 9.2.3 MEXICO
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 RUSSIA
  • 9.3.7 BENELUX
  • 9.3.8 NORDICS
  • 9.3.9 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 SOUTH KOREA
  • 9.4.5 AUSTRALIA & NEW ZEALAND
  • 9.4.6 REST OF ASIA-PACIFIC
• 9.5 SOUTH AMERICA
  • 9.5.1 BRAZIL
  • 9.5.2 ARGENTINA
  • 9.5.3 REST OF SOUTH AMERICA
• 9.6 MEA
  • 9.6.1 GCC COUNTRIES
  • 9.6.2 TURKEY
  • 9.6.3 NORTHERN AFRICA
  • 9.6.4 SOUTHERN AFRICA

10 COMPETITIVE LANDSCAPE

• 10.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL MOLECULAR BREEDING MARKET
• 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.5.1 EXPANSION
• 10.6 MAJOR PLAYERS FINANCIAL MATRIX
  • 10.6.1 SALES (USD BILLION),
  • 10.6.2 R&D (USD BILLION),

11 COMPANY PROFILES

• 11.1 CHARLES RIVER LABORATORIES
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS/SERVICES OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 EUROFINS SCIENTIFIC
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 SERVICS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 DANBRED P/S
  • 11.3.1 COMPANY OVERVIEWS
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 SERVICE OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 KEY STRATEGIES
• 11.4 INTERTEK GROUP PLC
  • 11.4.1 COMPANY OVERVIEWS
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 SERVICES OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 SLIPSTREAM AUTOMATION
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS/SERVICES OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 KEY STRATEGIES
• 11.6 ILLUMINA INC
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 THERMO FISHER SCIENTIFIC INC.
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 SWOT ANALYSIS
  • 11.7.5 KEY DEVELOPMENTS
  • 11.7.6 KEY STRATEGIES
• 11.8 LGC LIMITED
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 SOLUTIONS/SERVICES OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 SGS SOCIETE GENERALE DE SURVEILLANCE SA
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 LEMNATEC GMBH
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 SOLUTIONS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS